| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |